Ascendis Pharma AS (A71) — Capital Reinvestment Ratio
Ascendis Pharma AS (A71) has a Capital Reinvestment Ratio of 0.05x as of December 2025, meaning it reinvests 0% of its operating cash flow (€73.40 Million) in capital expenditures (€3.39 Million). Check Ascendis Pharma AS tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Ascendis Pharma AS Capital Reinvestment Ratio (2025–2025)
This chart tracks Ascendis Pharma AS's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see A71 cash flow conversion.
Annual Capital Reinvestment Ratio for Ascendis Pharma AS (2025–2025)
Year-by-year Capital Reinvestment Ratio for Ascendis Pharma AS from 2025 to 2025. See Ascendis Pharma AS (A71) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | €53.90 Million | €8.48 Million | — |